Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC/AHA Risk Calculator

REFERENCES

1. 1.↵
   1. Wallberg-Jonsson S,
   2. Ohman ML,
   3. Dahlqvist SR

   . Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445–51.

   OpenUrlPubMed
2. 2.↵
   1. Avina-Zubieta JA,
   2. Thomas J,
   3. Sadatsafavi M,
   4. Lehman AJ,
   5. Lacaille D

   . Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524–9.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Södergren A,
   2. Stegmayr B,
   3. Ohman ML,
   4. Wållberg-Jonsson S

   . Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis. Clin Exp Rheumatol 2009;27:641–4.

   OpenUrlPubMed
4. 4.↵
   1. Södergren A,
   2. Stegmayr B,
   3. Lundberg V,
   4. Ohman ML,
   5. Wållberg-Jonsson S

   . Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 2007;66:263–6.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Arts EE,
   2. Popa C,
   3. Den Broeder AA,
   4. Semb AG,
   5. Toms T,
   6. Kitas GD,
   7. et al.

   Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 2015;74:668–74.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Crowson CS,
   2. Matteson EL,
   3. Roger VL,
   4. Therneau TM,
   5. Gabriel SE

   . Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 2012;110:420–4.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Crowson CS,
   2. Gabriel SE,
   3. Semb AG,
   4. van Riel PLCM,
   5. Karpouzas G,
   6. Dessein PH,
   7. et al.

   Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatology 2017;56:1102–10.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Conroy RM,
   2. Pyörälä K,
   3. Fitzgerald AP,
   4. Sans S,
   5. Menotti A,
   6. Backer GD,
   7. et al.

   Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Arts EE,
   2. Popa CD,
   3. Den Broeder AA,
   4. Donders R,
   5. Sandoo A,
   6. Toms T,
   7. et al.

   Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis 2016;75:674–80.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Crowson CS,
    2. Rollefstad S,
    3. Kitas GD,
    4. van Riel PL,
    5. Gabriel SE,
    6. Semb AG,
    7. a Trans-Atlantic Cardiovascular Risk Consortium for Rheumatoid Arthritis (ATACC-RA)

    . Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis. PLoS One 2017;12: e0175605.

    OpenUrl
11. 11.↵
    1. Solomon DH,
    2. Greenberg J,
    3. Curtis JR,
    4. Liu M,
    5. Farkouh ME,
    6. Tsao P,
    7. et al.

    Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: A Consortium of Rheumatology Researchers of North America Registry study. Arthritis Rheumatol 2015;67:1995–2003.

    OpenUrl
12. 12.↵
    1. Arnett FC,
    2. Edworthy SM,
    3. Bloch DA,
    4. McShane DJ,
    5. Fries JF,
    6. Cooper NS,
    7. et al.

    The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Innala L,
    2. Sjöberg C,
    3. Möller B,
    4. Ljung L,
    5. Smedby T,
    6. Södergren A,
    7. et al.

    Co-morbidity in patients with early rheumatoid arthritis - inflammation matters. Arthritis Res Ther 2016;18:33.

    OpenUrl
14. 14.↵
    1. Ekdahl C,
    2. Eberhardt K,
    3. Andersson SI,
    4. Svensson B

    . Assessing disability in patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:263–71.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Swedish National Board of Health and Welfare statistics and data

    . [Internet. Accessed August 21, 2018.] Available from: http://www.socialstyrelsen.se/statistics
16. 16.↵
    1. National Cholesterol Education Program (NCEP) Expert Panel on Detection

    . Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.

    OpenUrlFREE Full Text
17. 17.↵
    1. Goff DC Jr,
    2. Lloyd-Jones DM,
    3. Bennett G,
    4. Coady S,
    5. D’Agostino RB,
    6. Gibbons R,
    7. et al.

    2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;25 Suppl 2:S49–73.

    OpenUrl
18. 18.↵
    1. Agca R,
    2. Heslinga SC,
    3. Rollefstad S,
    4. Heslinga M,
    5. McInnes IB,
    6. Peters MJ,
    7. et al.

    EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017;76:17–28.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. van Breukelen-van der Stoep DF,
    2. van Zeben D,
    3. Klop B,
    4. van de Geijn GJ,
    5. Janssen HJ,
    6. van der Meulen N,
    7. et al.

    Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis. Rheumatology 2016;55:1210–6.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Maradit-Kremers H,
    2. Nicola PJ,
    3. Crowson CS,
    4. Ballman KV,
    5. Gabriel SE

    . Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722–32.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Wållberg-Jonsson S,
    2. Johansson H,
    3. Ohman ML,
    4. Rantapää-Dahlqvist S

    . Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562–71.

    OpenUrlPubMed
22. 22.↵
    1. Robertson J,
    2. Peters MJ,
    3. McInnes IB,
    4. Sattar N

    . Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 2013;9:513–23.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Stone NJ,
    2. Robinson JG,
    3. Lichtenstein AH,
    4. Bairey Merz CN,
    5. Blum CB,
    6. Eckel RH,
    7. et al.

    2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol 2014;63:2889–934.

    OpenUrlFREE Full Text